)
James River Group Holdings (JRVR) investor relations material
James River Group Holdings Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 net loss available to common shareholders was $189.4M, or $4.08 per diluted share, including a non-cash $181.8M goodwill impairment.
Adjusted net operating loss was $4.4M, or $0.10 per diluted share, versus $17.4M of adjusted net operating income a year earlier.
Underwriting loss reached $20.0M as premiums declined and prior-year reserve development turned adverse; active E&S division submissions rose 8% YoY.
Financial highlights
Q3 total revenue was $147.7M versus $172.7M YoY; net earned premiums fell 14.0% to $127.7M.
Gross written premiums were $186.1M, down 21.6% YoY; net written premiums were $105.0M, down 14.4%.
Nine-month total revenue was $460.4M versus $519.9M; net earned premiums declined 11.2% to $402.4M.
Net investment income rose 1.2% to $22.2M in Q3 and 2.2% to $63.8M for nine months.
G&A expenses declined 9.2% in Q3 and 9.0% for nine months, largely from lower compensation costs.
Outlook and guidance
Underwriting remains focused on profitable growth in smaller E&S accounts; policies with premiums of $35,000 or less represent over 80% of policy count.
E&S renewal rates were generally flat YoY; increased competition reduced quote-to-bind conversion.
Kalepa underwriting workbench rollout showed initial productivity gains; three departments were onboarded and three more were in process.
Specialty Admitted operations were expected to continue with limited net exposure and further cost reductions.
- Proxy covers director elections, auditor ratification, and executive pay, with strong governance focus.JRVR
Proxy filing - Net income rose 59% year-over-year, E&S combined ratio was 92.8%, and expenses declined.JRVR
Q2 2026 - Net loss of $10.9M driven by E&S reinsurance charge; E&S segment led growth amid lower premiums.JRVR
Q1 2026 - 2025 marked a sharp turnaround to profitability, capital growth, and E&S-driven operational gains.JRVR
Q4 2025 - Over 21 million common shares registered for resale by major investors, with no proceeds to the company.JRVR
Registration Filing - Annual Meeting to vote on directors, auditor, compensation, and incentive plan amendments.JRVR
Proxy Filing - Earnings rose on investment gains and strategic actions, but reserve and legal risks persist.JRVR
Q2 2024 - Q3 net loss of $40.7M driven by reserve charges, with E&S premium growth and strategic actions.JRVR
Q3 2024 - Q4 2024 net loss of $92.7M; E&S premiums top $1B; 2025 outlook positive.JRVR
Q4 2024
)
)
)
)
)
)
)
)